29th November 2021 – Novogene, a leading provider of genomic services and solutions today, announced that it will be launching its single cell sequencing services specially for their Japanese customers at the 44th Annual Meeting of the Molecular Biological Society of Japan (MSBJ), Japan. This new service features an on-site service for Novogene Japan K.K. to support customers in optimising their single cell preparation work. It offers the flexibility for researchers to enjoy a reliable and seamless experience of an end-to-end sequencing solution of their single cell research from experimental project design, cell barcoding, library preparation, sequencing and bioinformatic analysis.
Earlier March this year, NovogeneAIT Genomics, a joint venture between Novogene and AIT Biotech, established a new lab in Singapore to provide dedicated single cell sequencing services for Scientists in basic and clinical research. “We are all very excited to bring our single cell sequencing solutions closer to our Japanese customers, paving accessibility for researchers using this application to identify new
biomarkers and drug targets for precise biological functions.”, said Justin Lee, Vice President of Novogene AMEA (Asia Pacific, Middle East and Africa).
Both laboratories in Japan and Singapore will offer its single cell sequencing services on the 10x Genomics Chromium System and Illumina platforms.
“Reliability in service and data quality, together with the right experiences, are what we aspire to achieve as a trusted research partner for our customers in genomic solutions. Professionalism and partnerships are values that we uphold in our team to help researchers achieve their single cell research in every step of the single cell sequencing process.”, added Yuji Katagiri, President of Novogene Japan K.K.
Highlights at the MBSJ, (Booth A01):
Register your interests with Novogene at the MBSJ here: om.novogene.com/MBSJ44_LP
Single cell sequencing services will be available to all customers in Japan starting 1st December 2021. For more information about the single cell sequencing services provided by Novogene AMEA, visit https://www.novogene.com/us-en/landing-page/single-cell-sequencing/.
Novogene was founded in Beijing, China, in 2011, with a mission to advance genomics and improve life. It is now a leading provider of genomics services and solutions for the research and clinical fields with branches in Hong Kong China, US, UK, Singapore, Netherlands and Japan. Novogene has global genomic sequencing labs in the US (at The University of California at Davis campus), China, Singapore, and the UK (Cambridge).
Novogene has strong scientific expertise and experience with 37 NGS-related patents and over 670 research papers with total impact factors at more than 4930, including publications in first-tier journals such as Cell, Nature and Science. To learn more, visit novogene.com/us-en.
The field is required.